What is the CPT (Current Procedural Terminology) code for a COVID‑19 test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CPT Codes for COVID-19 Testing

The specific CPT codes for COVID-19 testing depend on the test type: use CPT 87635 for SARS-CoV-2 molecular/NAAT testing (the gold standard), and CPT 87426 for rapid antigen testing.

Understanding COVID-19 Test CPT Coding

The Current Procedural Terminology (CPT) coding system provides standardized numerical codes for reporting medical procedures, which is essential for reimbursement and compliance. For COVID-19 diagnostic testing, the codes vary based on the testing methodology employed.

Primary CPT Codes by Test Type

Molecular Testing (NAAT/RT-PCR):

  • CPT 87635: SARS-CoV-2 amplified probe technique (the most commonly used code for molecular testing including RT-PCR, rapid molecular tests, and laboratory-based NAATs)
  • This applies to both rapid molecular tests (≤60-minute turnaround) and standard laboratory-based nucleic acid amplification tests 1, 2

Antigen Testing:

  • CPT 87426: SARS-CoV-2 antigen detection by immunoassay technique
  • This covers both point-of-care rapid antigen tests and laboratory-based antigen immunoassays 2

Clinical Context for Test Selection

The choice between molecular and antigen testing impacts both clinical decision-making and coding:

For symptomatic patients suspected of COVID-19:

  • NAAT (CPT 87635) is strongly recommended as the reference standard with highest sensitivity 1
  • Antigen testing (CPT 87426) is acceptable when NAAT results would be delayed >1 day, though negative results require NAAT confirmation if clinical suspicion remains high 2

For asymptomatic exposed individuals:

  • Either NAAT or antigen testing may be appropriate depending on timing and clinical context 1, 2
  • Testing should occur at least 5 days post-exposure for optimal sensitivity

Important Coding Considerations

Specimen collection codes may be billed separately depending on payer policies and collection method (nasopharyngeal, anterior nares, midturbinate, saliva, etc.) 1, 2.

Common pitfall: Do not confuse the test methodology with the specimen type—the CPT code reflects the laboratory technique (molecular vs. antigen), not where the swab was obtained.

Point-of-care vs. laboratory-based testing both use the same CPT codes; the location of testing does not change the procedural code 2.

Additional Coding Notes

For home testing or self-collection scenarios, the same CPT codes apply when results are reported to healthcare providers for clinical decision-making 2. However, over-the-counter home tests purchased directly by patients without provider involvement typically are not billed using these codes.

Accurate CPT coding is crucial for appropriate reimbursement and compliance—erroneous coding can result in revenue loss or significant penalties 3.

Related Questions

Which individual has authority to declare a public health emergency that permits the use of unapproved medical products, such as COVID‑19 vaccines?
How should a persistent productive cough after COVID‑19 be evaluated and managed in a stable patient without red‑flag symptoms?
What CPT (Current Procedural Terminology) code(s) are reported for trigger point injections with 0.25% bupivacaine into the rhomboid major, rhomboid minor, and levator scapular muscles?
What is the appropriate management for a 54-year-old man with sore throat, erythematous exudative tonsils, low‑grade fever, profuse nasal discharge, cough due to postnasal drip, no cervical lymphadenopathy, normal lung auscultation, and a negative COVID‑19 test?
What is the correct CPT (Current Procedural Terminology) code for a transforaminal epidural injection procedure, where a spinal needle is inserted using a transforaminal approach, causing paresthesia in the left lower extremities, and anesthetic drug is injected into the epidural space for a patient with multilevel lumbar degenerative disc disease?
What is the appropriate management for elevated blood pressure on postoperative day 2?
How should a 13-year-old male with intermittent dizziness be evaluated and managed?
How should postoperative hypertension be managed in an 18-year-old patient with no prior antihypertensive therapy and a family history of hypertension?
What are the characteristics of the GlideScope video laryngoscope?
What is the maximum recommended daily dose of doxepin for treating depression?
What are the considerations for ongoing management of thrombocytopenia, including contraindicated medications and supplements and long‑term complications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.